Ositag 80 mg (Osimertinib) is a targeted therapy for EGFR-mutated non-small cell lung cancer (NSCLC). It blocks abnormal cancer cell growth and spread. Common side effects include rash, diarrhea, dry skin, and nail changes. Use only under medical supervision. https://www.jkmedicine.com/product/details/124